Virus-induced senescence is a driver and therapeutic target in COVID-19Soyoung Lee, Clemens A. Schmitt, Yong Yu et al.|Nature|2021Cited by 344
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Anna C. Obenauf, Guillem Estivill et al.|Nature|2024Cited by 122
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumoursCiro Celsa, Fable Zustovich, Brooke Wietharn et al.|Journal of Hepatology|2023Cited by 62
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Johann von Felden, Giuseppe Cabibbo et al.|Hepatology|2024Cited by 52
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B DysfunctionClaudia Angela Maria Fulgenzi, Calogero Cammà, Bernhard Scheiner et al.|JAMA Oncology|2024Cited by 37